Good to see another company on the ASX draw attention to Pancreatic cancer with asx ticker code ATX in Phase 2a trials with FDA Designation. . Interesting that Oncosil is actually commercially selling with improving sales , further expansion to come, awaiting approvals, in clinical trials and has been trading recently in a similar Market Cap range approximately around the $ 40 to $ 50 million range.
Ann: Two more PANCOSIL Trial treatments using OncoSil device, page-263
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
-0.001(11.1%) |
Mkt cap ! $30.27M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.9¢ | 0.8¢ | $60.16K | 7.448M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 41 | 14420152 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 7652730 | 8 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| OSL (ASX) Chart |